| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Scadden David is a Director at Dianthus Therapeutics, Inc. /DE/ with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $19.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 200 | $43.84 | $8,768.00 | -1.1% | -37.8% | - | |
| Oct 8, 2025 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 200 | $41.00 | $8,200.00 | -1.1% | -35.5% | - | |
| Sep 30, 2025 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 200 | $40.00 | $8,000.00 | -1.1% | -32.3% | - | |
| Aug 27, 2025 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 200 | $40.00 | $8,000.00 | -1.1% | -27.6% | - | |
| Jul 10, 2025 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 1,400 | $40.00 | $56,000.00 | -7.4% | +7.8% | - | |
| Dec 11, 2024 | AGIO Agios Pharmaceuticals, Inc. | Director | Sale+OE | 200 | $46.28 | $9,256.00 | -1.3% | -25.9% | -36.7% | |
| Jun 25, 2018 | DNTH Dianthus Therapeutics, Inc. /de/ | Director | Buy | 6,600 | $15.00 | $99,000.00 | +3.0% | - | - | |
| Mar 16, 2018 | AGIO Agios Pharmaceuticals, Inc. | Director | Buy | 200 | $83.44 | $16,688.00 | +53.9% | - | - |